Harvard Management as of March 31, 2022
Portfolio Holdings for Harvard Management
Harvard Management holds 44 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Meta Platforms Cl A (META) | 27.6 | $274M | 1.2M | 222.36 | |
| Alphabet Cap Stk Cl A (GOOGL) | 24.4 | $242M | 87k | 2781.35 | |
| Scientific Games (LNW) | 15.9 | $157M | 2.7M | 58.75 | |
| Abcellera Biologics (ABCL) | 4.0 | $40M | 4.1M | 9.75 | |
| Eqrx | 2.2 | $22M | 5.3M | 4.13 | |
| Purecycle Technologies (PCT) | 2.0 | $20M | 2.5M | 8.00 | |
| Revolution Medicines (RVMD) | 1.7 | $17M | 670k | 25.51 | |
| Relay Therapeutics (RLAY) | 1.6 | $16M | 541k | 29.93 | |
| 10x Genomics Cl A Com (TXG) | 1.4 | $14M | 186k | 76.07 | |
| Grab Holdings Class A Ord (GRAB) | 1.3 | $13M | 3.7M | 3.50 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 1.1 | $11M | 1.5M | 7.16 | |
| Meli Kaszek Pioneer Corp Class A Ord | 1.0 | $10M | 1.0M | 10.28 | |
| Fulcrum Therapeutics (FULC) | 1.0 | $9.7M | 411k | 23.65 | |
| Rocket Lab Usa | 0.8 | $8.1M | 1.0M | 8.05 | |
| Affirm Hldgs Com Cl A (AFRM) | 0.8 | $8.0M | 174k | 46.28 | |
| Micron Technology (MU) | 0.8 | $8.0M | 103k | 77.89 | |
| Praxis Precision Medicines I | 0.8 | $7.9M | 779k | 10.21 | |
| Tenaya Therapeutics (TNYA) | 0.8 | $7.9M | 673k | 11.78 | |
| Intel Corporation (INTC) | 0.8 | $7.5M | 151k | 49.56 | |
| NVIDIA Corporation (NVDA) | 0.7 | $7.2M | 26k | 272.85 | |
| Analog Devices (ADI) | 0.7 | $6.9M | 42k | 165.17 | |
| Lam Research Corporation | 0.7 | $6.7M | 13k | 537.58 | |
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.7 | $6.7M | 64k | 104.26 | |
| Applied Materials (AMAT) | 0.7 | $6.7M | 51k | 131.80 | |
| Advanced Micro Devices (AMD) | 0.6 | $6.0M | 55k | 109.34 | |
| Qorvo (QRVO) | 0.6 | $5.8M | 47k | 124.10 | |
| Kinnate Biopharma | 0.6 | $5.6M | 498k | 11.26 | |
| Tango Therapeutics (TNGX) | 0.5 | $5.4M | 708k | 7.58 | |
| Confluent Class A Com (CFLT) | 0.5 | $5.3M | 130k | 41.00 | |
| Nurix Therapeutics (NRIX) | 0.4 | $4.4M | 315k | 14.01 | |
| Pliant Therapeutics (PLRX) | 0.4 | $3.9M | 562k | 7.01 | |
| Sana Biotechnology (SANA) | 0.4 | $3.9M | 469k | 8.26 | |
| Generation Bio | 0.4 | $3.7M | 510k | 7.34 | |
| Xilio Therapeutics (XLO) | 0.3 | $2.9M | 416k | 7.07 | |
| Pardes Biosciences | 0.3 | $2.9M | 400k | 7.22 | |
| Surrozen | 0.3 | $2.5M | 827k | 3.01 | |
| Pacific Biosciences of California (PACB) | 0.2 | $2.1M | 229k | 9.10 | |
| Purecycle Technologies *w Exp 03/17/202 (PCTTW) | 0.2 | $2.0M | 714k | 2.87 | |
| Vigil Neuroscience (VIGL) | 0.2 | $2.0M | 290k | 7.03 | |
| Dyne Therapeutics (DYN) | 0.1 | $1.0M | 107k | 9.64 | |
| Decibel Therapeutics | 0.1 | $1.0M | 329k | 3.04 | |
| Magenta Therapeutics | 0.1 | $965k | 333k | 2.90 | |
| Seres Therapeutics | 0.1 | $939k | 132k | 7.12 | |
| Gemini Therapeutics | 0.0 | $348k | 250k | 1.39 |
